Paradigm Biocapital Advisors LP
Paradigm Biocapital Advisors LP reported 28 holdings worth US$5.34B as of Jun 30, 2026 (Form 13F)
As of Jun 30, 2026 · Filed Aug 14, 2026
Paradigm Biocapital Advisors LP reported 28 holdings worth US$5.34B as of Jun 30, 2026. Largest: Revolution Medicines, Inc., Nuvalent, Inc. and Edgewise Therapeutics, Inc. Filed Aug 14, 2026 (Form 13F).
- Holdings
- 28
- Value as reported
- US$5.34B
The filing in full
| Company | Shares | Value as reported | % of portfolio |
|---|
| Revolution Medicines, Inc. | 6.36M | US$1.19B | 22.3% |
| Nuvalent, Inc. | 5.92M | US$732M | 13.7% |
| Edgewise Therapeutics, Inc. | 10.2M | US$415M | 7.8% |
| Genmab A/s | 13.1M | US$361M | 6.8% |
| Spyre Therapeutics, Inc. | 3.84M | US$341M | 6.4% |
| Apogee Therapeutics, Inc. | 1.58M | US$209M | 3.9% |
| Oruka Therapeutics, Inc. | 2.14M | US$204M | 3.8% |
| Tango Therapeutics, Inc. | 6.36M | US$199M | 3.7% |
| Erasca, Inc. | 9.55M | US$175M | 3.3% |
| Tarsus Pharmaceuticals, Inc. | 2.78M | US$175M | 3.3% |
| Alnylam Pharmaceuticals, Inc. | 480K | US$144M | 2.7% |
| Insmed Incorporated | 1.33M | US$141M | 2.6% |
| Mbx Biosciences, Inc. | 2.51M | US$138M | 2.6% |
| Vaxcyte, Inc. | 2.13M | US$124M | 2.3% |
| Viridian Therapeutics, Inc. | 6.72M | US$124M | 2.3% |
| Olema Pharmaceuticals, Inc. | 8.67M | US$108M | 2.0% |
| Jade Biosciences, Inc. | 2.86M | US$63.5M | 1.2% |
| Tyra Biosciences, Inc. | 1.83M | US$58.4M | 1.1% |
| Assembly Biosciences, Inc. | 1.55M | US$42.7M | 0.80% |
| Eyepoint, Inc. | 2.89M | US$41.3M | 0.77% |
| Achieve Life Sciences, Inc. | 4.95M | US$32.3M | 0.61% |
| Vor Biopharma Inc. | 1.75M | US$32.2M | 0.60% |
| Maplight Therapeutics, Inc. | 686K | US$24.6M | 0.46% |
| Kardigan, Inc. | 900K | US$21.5M | 0.40% |
| Lexeo Therapeutics, Inc. | 4.18M | US$19.4M | 0.36% |
| Editas Medicine, Inc. | 5.59M | US$18.1M | 0.34% |
| Inventiva Sa | 4M | US$15.1M | 0.28% |
| Mirum Pharmaceuticals, Inc. | 0 | US$0 | 0.00% |
| Oric Pharmaceuticals, Inc. | 0 | US$0 | 0.00% |
| Scholar Rock Holding Corporation | 0 | US$0 | 0.00% |
| Terns Pharmaceuticals, Inc. | 0 | US$0 | 0.00% |
| Veradermics, Incorporated | 0 | US$0 | 0.00% |
| Abivax Sa | 0 | US$0 | 0.00% |
| Bridgebio Oncology Therapeutics, Inc. | 0 | US$0 | 0.00% |
| Cytokinetics, Incorporated | 0 | US$0 | 0.00% |
| Kalaris Therapeutics, Inc. | 0 | US$0 | 0.00% |
| Maze Therapeutics, Inc. | 0 | US$0 | 0.00% |
Source
View original at SEC
Related